{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T03:10:40Z","timestamp":1778987440915,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dysphagia"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bulbar and jaw muscles are impaired in patients with Spinal Muscular Atrophy (SMA) but the assessment of their severity and progression are limited by the lack of age-appropriate and disease-specific measures. We investigated mastication and swallowing in children and adults with SMA, sitters and walkers. In a 2-year multicentre cross-sectional prospective study, lip and tongue strength (Iowa Oral Performance Instrument), chewing and swallowing (Test of Masticating and Swallowing Solids), active mouth opening (aMMO) were compared to age-appropriate normative data. The perceived burden of oro-bulbar involvement (SMA-Health Index) was recorded. 78 patients were included, 45 children (median age 7.4\u00a0years),22 adults (median age 26.8\u00a0years) on nusinersen and 11 untreated (median age 32.7\u00a0years). Forty-three percent children had reduced mouth opening, 50% had prolonged total time to eat. These issues were more prominent in sitters than in walkers (<jats:italic>p<\/jats:italic>\u2009=\u20090.019, <jats:italic>p<\/jats:italic>\u2009=\u20090.014). Sixty-six percent needed increased swallows for bolus clearance. Nusinersen treated adults had median aMMO, tongue strength and total time at TOMASS values within normal range (<jats:italic>z<\/jats:italic> score: \u22121.40, \u22121.22, \u22121.32, respectively) whereas untreated adults had reduced aMMO (<jats:italic>z<\/jats:italic> score: \u22122.68) and tongue strength (<jats:italic>z<\/jats:italic> score: \u22122.20). Only a minority of children (2\/17) and treated adults (5\/21) reported burden in swallowing or mastication compared to all untreated adults (5\/5). After 16\u00a0months, mastication and swallowing were stable in treated children and adults, whether sitters or walkers. The reported multimodal approach to assess oro-bulbar functions demonstrate that swallowing and mastication are impaired in SMA despite patients\u2019 perception. These results suggest a trend towards stabilization of oro-bulbar function in patients on long-term treatment with nusinersen.<\/jats:p>","DOI":"10.1007\/s00455-023-10584-z","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T09:02:26Z","timestamp":1686214946000},"page":"1568-1580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Assessing Prevalence and Characteristics of Oro-bulbar Involvement in Children and Adults with SMA Type 2 and 3 Using a Multimodal Approach"],"prefix":"10.1007","volume":"38","author":[{"given":"Federica","family":"Trucco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Salmin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Lizio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Coratti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Albamonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Chiara","family":"Frisoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Carraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Lops","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacopo","family":"Casiraghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Di Bari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Berti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Stanca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marika","family":"Pane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad","family":"Heatwole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuran","family":"Dilek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria Ada","family":"Sansone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"issue":"5","key":"10584_CR1","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/mus.23967","volume":"49","author":"PB Kang","year":"2014","unstructured":"Kang PB, et al. The motor neuron response to SMN1 deficiency in spinal muscular atrophy. Muscle Nerve. 2014;49(5):636\u201344.","journal-title":"Muscle Nerve"},{"issue":"6","key":"10584_CR2","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s11011-018-0285-4","volume":"33","author":"P Sneha","year":"2018","unstructured":"Sneha P, et al. Impact of missense mutations in survival motor neuron protein (SMN1) leading to Spinal Muscular Atrophy (SMA): a computational approach. Metab Brain Dis. 2018;33(6):1823\u201334.","journal-title":"Metab Brain Dis"},{"issue":"9630","key":"10584_CR3","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","volume":"371","author":"MR Lunn","year":"2008","unstructured":"Lunn MR, Wang CH. Spinal muscular atrophy. The Lancet. 2008;371(9630):2120\u201333.","journal-title":"The Lancet"},{"issue":"2","key":"10584_CR4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, et al. Diagnosis and management of spinal muscular atrophy: Part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28(2):103\u201315.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10584_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","volume":"28","author":"RS Finkel","year":"2018","unstructured":"Finkel RS, et al. Diagnosis and management of spinal muscular atrophy: part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord. 2018;28(3):197\u2013207.","journal-title":"Neuromuscul Disord"},{"issue":"11","key":"10584_CR6","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.nmd.2016.10.002","volume":"26","author":"R De Sanctis","year":"2016","unstructured":"De Sanctis R, et al. Developmental milestones in type I spinal muscular atrophy. Neuromuscul Disord. 2016;26(11):754\u20139.","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10584_CR7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nmd.2015.10.006","volume":"26","author":"E Mercuri","year":"2016","unstructured":"Mercuri E, et al. Patterns of disease progression in type 2 and 3 SMA: implications for clinical trials. Neuromuscul Disord. 2016;26(2):126\u201331.","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10584_CR8","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/ana.25101","volume":"82","author":"SJ Kolb","year":"2017","unstructured":"Kolb SJ, et al. Natural history of infantile-onset spinal muscular atrophy. Ann Neurol. 2017;82(6):883\u201391.","journal-title":"Ann Neurol"},{"issue":"5","key":"10584_CR9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.nmd.2008.02.008","volume":"18","author":"S Messina","year":"2008","unstructured":"Messina S, et al. Feeding problems and malnutrition in spinal muscular atrophy type II. Neuromuscul Disord. 2008;18(5):389\u201393.","journal-title":"Neuromuscul Disord"},{"key":"10584_CR10","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1212\/WNL.0b013e3181c34aa6","volume":"73","author":"L van den Engel-Hoek","year":"2009","unstructured":"van den Engel-Hoek L, et al. Dysphagia in spinal muscular atrophy type II: more than a bulbar problem? Neurology. 2009;73:1787\u201391.","journal-title":"Neurology"},{"issue":"13","key":"10584_CR11","doi-asserted-by":"crossref","first-page":"e1206","DOI":"10.1212\/WNL.0000000000006241","volume":"91","author":"P Mongiovi","year":"2018","unstructured":"Mongiovi P, et al. Patient reported impact of symptoms in spinal muscular atrophy (PRISM-SMA). Neurology. 2018;91(13):e1206\u201314.","journal-title":"Neurology"},{"issue":"1","key":"10584_CR12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JND-180342","volume":"6","author":"S Dunaway Young","year":"2019","unstructured":"Dunaway Young S, et al. Perceived fatigue in spinal muscular atrophy: a pilot study. J Neuromuscul Dis. 2019;6(1):109\u201317.","journal-title":"J Neuromuscul Dis"},{"issue":"3","key":"10584_CR13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3233\/JND-190379","volume":"6","author":"AMB van der Heul","year":"2019","unstructured":"van der Heul AMB, et al. Bulbar problems self-reported by children and adults with spinal muscular atrophy. J Neuromuscul Dis. 2019;6(3):361\u20138.","journal-title":"J Neuromuscul Dis"},{"key":"10584_CR14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1212\/WNL.0000000000002348","volume":"86","author":"HW van Bruggen","year":"2016","unstructured":"van Bruggen HW, et al. Mandibular dysfunction as a reflection of bulbar involvement in SMA type 2 and 3. Neurology. 2016;86:552\u20139.","journal-title":"Neurology"},{"key":"10584_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00455-021-10351-y","author":"AMB van der Heul","year":"2021","unstructured":"van der Heul AMB, et al. Mastication in patients with spinal muscular atrophy types 2 and 3 is characterized by abnormal efficiency, reduced endurance, and fatigue. Dysphagia. 2021. https:\/\/doi.org\/10.1007\/s00455-021-10351-y.","journal-title":"Dysphagia"},{"issue":"2","key":"10584_CR16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.nmd.2020.12.007","volume":"31","author":"RI Wadman","year":"2021","unstructured":"Wadman RI, et al. Feeding difficulties in children and adolescents with spinal muscular atrophy type 2. Neuromuscul Disord. 2021;31(2):101\u201312.","journal-title":"Neuromuscul Disord"},{"issue":"11","key":"10584_CR17","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0003-9993(94)90001-9","volume":"75","author":"TN Willig","year":"1994","unstructured":"Willig TN, et al. Swallowing problems in neuromuscular disorders. Arch Phys Med Rehabil. 1994;75(11):1175\u201381.","journal-title":"Arch Phys Med Rehabil"},{"key":"10584_CR18","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0889-5406(99)70296-9","volume":"115","author":"MW Granger","year":"1999","unstructured":"Granger MW, et al. Masticatory muscle function in patients with spinal muscular atrophy. Am J Orthod Dentofac Orthop. 1999;115:697\u2013702.","journal-title":"Am J Orthod Dentofac Orthop"},{"issue":"11","key":"10584_CR19","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1177\/0883073811407696","volume":"26","author":"HW van Bruggen","year":"2011","unstructured":"van Bruggen HW, et al. Impaired mandibular function in spinal muscular atrophy type II: need for early recognition. J Child Neurol. 2011;26(11):1392\u20136.","journal-title":"J Child Neurol"},{"issue":"2","key":"10584_CR20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/joor.12728","volume":"46","author":"U Frank","year":"2019","unstructured":"Frank U, et al. International standardisation of the test of masticating and swallowing solids in children. J Oral Rehabil. 2019;46(2):161\u20139.","journal-title":"J Oral Rehabil"},{"key":"10584_CR21","doi-asserted-by":"crossref","first-page":"e1475","DOI":"10.1212\/WNL.0000000000012640","volume":"97","author":"R Kroon","year":"2021","unstructured":"Kroon R, et al. Longitudinal assessment of strength, functional capacity, oropharyngeal function, and quality of life in oculopharyngeal muscular dystrophy. Neurology. 2021;97:e1475\u201383.","journal-title":"Neurology"},{"issue":"4","key":"10584_CR22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3233\/JND-200614","volume":"8","author":"B Berti","year":"2021","unstructured":"Berti B, et al. Oral and swallowing abilities tool (OrSAT) for type 1 SMA patients: development of a new module. J Neuromuscul Dis. 2021;8(4):589\u2013601.","journal-title":"J Neuromuscul Dis"},{"key":"10584_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.15171","author":"H Weststrate","year":"2022","unstructured":"Weststrate H, et al. Evolution of bulbar function in spinal muscular atrophy type 1 treated with nusinersen. Dev Med Child Neurol. 2022. https:\/\/doi.org\/10.1111\/dmcn.15171.","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"10584_CR24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nmd.2021.02.006","volume":"31","author":"VA Sansone","year":"2021","unstructured":"Sansone VA, et al. The spinal muscular atrophy health index: Italian validation of a disease-specific outcome measure. Neuromuscul Disord. 2021;31(5):409\u201318.","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"10584_CR25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1469-8749.2004.tb00508.x","volume":"46","author":"LM Gauld","year":"2007","unstructured":"Gauld LM, et al. Height prediction from ulna length. Dev Med Child Neurol. 2007;46(7):475\u201380.","journal-title":"Dev Med Child Neurol"},{"key":"10584_CR26","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/17477161003615583","volume":"5","author":"M de Onis","year":"2010","unstructured":"de Onis M, Fau-Lobstein T, Lobstein T. Defining obesity risk status in the general childhood population: which cut-offs should we use? Int J Pediatr Obes. 2010;5:458\u201360.","journal-title":"Int J Pediatr Obes"},{"key":"10584_CR27","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/ajcn\/64.4.650","volume":"64","author":"M de Onis","year":"1996","unstructured":"de Onis M, Habicht JP. Anthropometric reference data for international use: recommendations from a World Health Organization expert committee. Am J Clin Nutr. 1996;64:650\u20138.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10584_CR28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/09638288.2014.921245","volume":"37","author":"V Adams","year":"2015","unstructured":"Adams V, et al. Reliability of measurements of tongue and hand strength and endurance using the Iowa Oral performance instrument with elderly adults. Disabil Rehabil. 2015;37(5):389\u201395.","journal-title":"Disabil Rehabil"},{"issue":"2","key":"10584_CR29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00455-012-9425-x","volume":"28","author":"J Vanderwegen","year":"2013","unstructured":"Vanderwegen J, et al. The influence of age, sex, bulb position, visual feedback, and the order of testing on maximum anterior and posterior tongue strength and endurance in healthy belgian adults. Dysphagia. 2013;28(2):159\u201366.","journal-title":"Dysphagia"},{"issue":"6","key":"10584_CR30","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s00455-019-09976-x","volume":"34","author":"J Vanderwegen","year":"2019","unstructured":"Vanderwegen J, et al. The influence of age, sex, visual feedback, bulb position, and the order of testing on maximum anterior and posterior tongue strength in healthy belgian children. Dysphagia. 2019;34(6):834\u201351.","journal-title":"Dysphagia"},{"issue":"1","key":"10584_CR31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00455-011-9328-2","volume":"27","author":"HM Clark","year":"2012","unstructured":"Clark HM, Solomon NP. Age and sex differences in orofacial strength. Dysphagia. 2012;27(1):2\u20139.","journal-title":"Dysphagia"},{"issue":"4","key":"10584_CR32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00455-009-9215-2","volume":"24","author":"NL Potter","year":"2009","unstructured":"Potter NL, Short R. Maximal tongue strength in typically developing children and adolescents. Dysphagia. 2009;24(4):391\u20137.","journal-title":"Dysphagia"},{"key":"10584_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1546-0096-11-1","volume":"11","author":"L M\u00fcller","year":"2013","unstructured":"M\u00fcller L, et al. Maximal mouth opening capacity: percentiles for healthy children 4\u201317 years of age. Pediatrc Rheumatol. 2013;11:1\u20137.","journal-title":"Pediatrc Rheumatol"},{"key":"10584_CR34","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.joms.2020.06.018","volume":"78","author":"A Venkatraman","year":"2020","unstructured":"Venkatraman A, Kaval F, Takiar V. Body mass index and age affect maximum mouth opening in a contemporary american population. J Oral Maxillofac Surg. 2020;78:1926\u201332.","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"10584_CR35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/1460-6984.12332","volume":"53","author":"ML Huckabee","year":"2018","unstructured":"Huckabee ML, et al. The test of masticating and swallowing solids (TOMASS): reliability, validity and international normative data. Int J Lang Commun Disord. 2018;53(1):144\u201356.","journal-title":"Int J Lang Commun Disord"},{"issue":"6","key":"10584_CR36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mus.27223","volume":"63","author":"CE Zizzi","year":"2021","unstructured":"Zizzi CE, et al. The spinal muscular atrophy health index: a novel outcome for measuring how a patient feels and functions. Muscle Nerve. 2021;63(6):837\u201344.","journal-title":"Muscle Nerve"},{"issue":"3","key":"10584_CR37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/mus.27644","volume":"66","author":"A Mazzella","year":"2022","unstructured":"Mazzella A, et al. Assessing perspectives of disease burden and clinically meaningful changes using the spinal muscular atrophy health index in adolescents and young adults. Muscle Nerve. 2022;66(3):276\u201381.","journal-title":"Muscle Nerve"},{"issue":"11","key":"10584_CR38","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.joms.2020.06.018","volume":"78","author":"A Venkatraman","year":"2020","unstructured":"Venkatraman A, Kaval F, Takiar V. Body mass index and age affect maximum mouth opening in a contemporary american population. J Oral Maxillofac Surg. 2020;78(11):1926\u201332.","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"10584_CR39","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jpeds.2011.08.016","volume":"160","author":"YS Chen","year":"2012","unstructured":"Chen YS, et al. Prevalence and risk factors for feeding and swallowing difficulties in spinal muscular atrophy types II and III. J Pediatr. 2012;160(3):447-451 e1.","journal-title":"J Pediatr"},{"key":"10584_CR40","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1212\/WNL.0000000000000796","volume":"83","author":"RI Wadman","year":"2014","unstructured":"Wadman RI, et al. Bulbar muscle MRI changes in patients with SMA with reduced mouth opening and dysphagia. Neurology. 2014;83:1060\u20136.","journal-title":"Neurology"},{"issue":"8","key":"10584_CR41","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/acn3.425","volume":"4","author":"H Banno","year":"2017","unstructured":"Banno H, et al. Swallowing markers in spinal and bulbar muscular atrophy. Ann Clin Transl Neurol. 2017;4(8):534\u201343.","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"10584_CR42","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1044\/2021_AJSLP-20-00217","volume":"30","author":"KE McGrattan","year":"2021","unstructured":"McGrattan KE, et al. Dysphagia phenotypes in spinal muscular atrophy: the past, present, and promise for the future. Am J Speech Lang Pathol. 2021;30(3):1008\u201322.","journal-title":"Am J Speech Lang Pathol"},{"key":"10584_CR43","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000206826","author":"A Chacko","year":"2023","unstructured":"Chacko A, et al. Dysphagia and lung disease in children with spinal muscular atrophy treated with disease modifying agents. Neurology. 2023. https:\/\/doi.org\/10.1212\/WNL.0000000000206826.","journal-title":"Neurology"},{"issue":"1","key":"10584_CR44","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s13023-021-02015-9","volume":"16","author":"R De Amicis","year":"2021","unstructured":"De Amicis R, et al. Growth patterns in children with spinal muscular atrophy. Orphanet J Rare Dis. 2021;16(1):375.","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"10584_CR45","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1710504","volume":"378","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, et al. Nusinersen versus sham control in later-onset spinal muscular atrophy. N Engl J Med. 2018;378(7):625\u201335.","journal-title":"N Engl J Med"},{"issue":"1","key":"10584_CR46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(21)00367-7","volume":"21","author":"E Mercuri","year":"2022","unstructured":"Mercuri E, et al. Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2022;21(1):42\u201352.","journal-title":"Lancet Neurol"},{"issue":"4","key":"10584_CR47","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1474-4422(20)30037-5","volume":"19","author":"T Hagenacker","year":"2020","unstructured":"Hagenacker T, et al. Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study. Lancet Neurol. 2020;19(4):317\u201325.","journal-title":"Lancet Neurol"},{"issue":"11","key":"10584_CR48","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/jnnp-2020-323822","volume":"91","author":"L Maggi","year":"2020","unstructured":"Maggi L, et al. Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3. J Neurol Neurosurg Psychiatry. 2020;91(11):1166\u201374.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10584_CR49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/thoraxjnl-2020-216564","volume":"77","author":"A Chacko","year":"2022","unstructured":"Chacko A, et al. Effect of nusinersen on respiratory function in paediatric spinal muscular atrophy types 1\u20133. Thorax. 2022;77(1):40\u20136.","journal-title":"Thorax"},{"issue":"1","key":"10584_CR50","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/s13023-021-02065-z","volume":"16","author":"G Coratti","year":"2021","unstructured":"Coratti G, et al. Motor function in type 2 and 3 SMA patients treated with nusinersen: a critical review and meta-analysis. Orphanet J Rare Dis. 2021;16(1):430.","journal-title":"Orphanet J Rare Dis"}],"container-title":["Dysphagia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00455-023-10584-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00455-023-10584-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00455-023-10584-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T11:07:57Z","timestamp":1698404877000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00455-023-10584-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10584"],"URL":"https:\/\/doi.org\/10.1007\/s00455-023-10584-z","relation":{},"ISSN":["0179-051X","1432-0460"],"issn-type":[{"value":"0179-051X","type":"print"},{"value":"1432-0460","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]},"assertion":[{"value":"13 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Chad Heatwole receives royalties for the use of multiple disease specific instruments. He has provided consultation to Biogen Idec, Ionis Pharmaceuticals, aTyr Pharma, AMO Pharma, Acceleron Pharma, Cytokinetics, Expansion Therapeutics, Harmony Biosciences, Regeneron Pharmaceuticals, Astellas Pharmaceuticals, AveXis, Recursion Pharmaceuticals, IRIS Medicine, Inc., Takeda Pharmaceutical Company, Scholar Rock, Avidity Biosciences, Novartis Pharmaceuticals Corporation, SwanBio Therapeutics, Neurocrine Biosciences, and the Marigold Foundation. He receives grant support from the Department of Defense, Duchenne UK, Parent Project Muscular Dystrophy, Recursion Pharmaceuticals, Swan Bio Therapeutics, the National Institute of Neurological Disorders and Stroke, the Muscular Dystrophy Association, the Friedreich\u2019s Ataxia Research Alliance, Cure Spinal Muscular Atrophy, the Amyotrophic Lateral Sclerosis Association, the University of Miami, Novartis Pharmaceuticals Corporation, and the Michael J. Foxx Foundation. He is the director of the University of Rochester\u2019s Center for Health and Technology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}